These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 24529166

  • 1. A critical first assessment of the new pre-market approval regime for new psychoactive substances (NPS) in New Zealand.
    Wilkins C.
    Addiction; 2014 Oct; 109(10):1580-6. PubMed ID: 24529166
    [Abstract] [Full Text] [Related]

  • 2. The challenge of a ban on animal testing for the development of a regulated legal market for new psychoactive substances (NPS) ('legal highs') in New Zealand: Issues and options for resolution.
    Rychert M, Wilkins C.
    Int J Drug Policy; 2015 Dec; 26(12):1273-8. PubMed ID: 26364077
    [Abstract] [Full Text] [Related]

  • 3. The interim regulated legal market for NPS ('legal high') products in New Zealand: The impact of new retail restrictions and product licensing.
    Wilkins C.
    Drug Test Anal; 2014 Dec; 6(7-8):868-75. PubMed ID: 24817124
    [Abstract] [Full Text] [Related]

  • 4. Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances ('legal highs') in New Zealand.
    Rychert M, Wilkins C, Witten K.
    Drug Alcohol Rev; 2017 Sep; 36(5):589-596. PubMed ID: 28229493
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A critical analysis of the implementation of a legal regulated market for new psychoactive substances ("legal highs") in New Zealand.
    Rychert M, Wilkins C.
    Int J Drug Policy; 2018 May; 55():88-94. PubMed ID: 29524738
    [Abstract] [Full Text] [Related]

  • 9. Response to commentaries.
    Wilkins C.
    Addiction; 2014 Oct; 109(10):1593-4. PubMed ID: 25163708
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Is the recent ban on animal testing of legal high products a fatal blow to the development of a legal market for 'low-risk' psychoactive products in New Zealand?
    Rychert M, Wilkins C.
    Addiction; 2015 Apr; 110(4):714-5. PubMed ID: 25771695
    [No Abstract] [Full Text] [Related]

  • 17. Where is the pleasure?
    Ritter A.
    Addiction; 2014 Oct; 109(10):1587-8. PubMed ID: 25163703
    [No Abstract] [Full Text] [Related]

  • 18. Legal highs - legal aspects and legislative solutions.
    Kapka-Skrzypczak L, Kulpa P, Sawicki K, Cyranka M, Wojtyła A, Kruszewski M.
    Ann Agric Environ Med; 2011 Oct; 18(2):304-9. PubMed ID: 22216803
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.